Drug Master Files for: alogliptin benzoate
✉ Email this page to a colleague
alogliptin benzoate Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 27993 | A | II | 5/19/2014 | ALP PHARM BEIJING CO LTD | ALOGLIPTIN BENZOATE |
| 28187 | A | II | 4/24/2014 | BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD | ALOGLIPTIN BENZOATE |
| 29427 | A | II | 6/30/2015 | MSN LABORATORIES PRIVATE LTD | ALOGLIPTIN BENZOATE [ROUTE CODE LB] |
| 30057 | A | II | 2/8/2016 | GLENMARK PHARMACEUTICALS LTD | ALOGLIPTIN BENZOATE |
| 30093 | A | II | 12/30/2015 | ALEMBIC PHARMACEUTICALS LTD | ALOGLIPTIN BENZOATE |
| 30577 | A | II | 7/18/2016 | HONOUR LAB LTD | ALOGLIPTIN BENZOATE |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
